Funding for this research was provided by:
National Institute of General Medical Sciences (GM121499)
Article History
Received: 26 April 2021
Accepted: 15 September 2021
First Online: 22 September 2021
Declarations
:
: EMH holds shares of Acceleron Pharma. EMH is a shareholder and co-founder of Advertent Biotherapeutics. SA is an employee and holds stock options of Regeneron Pharma. JM has no competing interests.
: This article does not contain any studies with human participants or animals.
: All the authors gave consent for publication.